A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
Part of paid clinical trials in Bentonville, Arkansas.
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Study ID
- NCT06894212
- Phase
- PHASE3
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- SEP-363856 — DRUGtablet
- Placebo — OTHERtablet
Study Details
Evaluate the efficacy and safety of Ulotaront (SEP-363856) in acutely psychotic subjects with schizophrenia
Key Dates
- Start date
- Feb 28, 2025
- Status verified
- May 2026
- Primary completion
- Oct 20, 2026
- Completion
- Oct 29, 2026
Study Design
- Enrollment
- 522 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Placebo Comparator: PlaceboPlacebo
- Experimental: SEP-363856 75 mgSEP-363856 75 mg/day
- Experimental: SEP-363856 100 mgSEP-363856 100 mg/day
Primary Outcome Measure
The change from baseline in Positive And Negative Syndrome Scale (PANSS) total score at Week 6 [ Time Frame: Baseline to Week 6 ]
Central Contacts
- Otsuka Call Center844-687-8522
Locations (35)
Find similar trials in Bentonville, AR
By condition
By specialty
By research site
Pillar Clinical Research LLC - Bentonville Site· Bentonville, ARPillar Clinical Research (Little Rock AR) Site· Little Rock, ARWoodland International Research Group Site· Little Rock, ARWoodland Research Northwest Site· Rogers, ARClinical Innovations, Inc. dba CITrials (Bellflower)· Bellflower, CAProScience Research Group Site· Culver City, CA
Related Studies
- Database Registry for Neural Network Biomarkers in PsychosisRecruiting · University of Texas Southwestern Medical Center · Dallas, Texas
- Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With SchizophreniaPHASE3 · Recruiting · Gedeon Richter Plc. · Culver City, California
- Ocrelizumab for Psychosis by AutoimmunityPHASE1/PHASE2 · Recruiting · The Methodist Hospital Research Institute · Houston, Texas
- Imaging Synapses With [11C] UCB-J in the Human BrainPHASE1 · Recruiting · Davidzon, Guido, M.D. · Palo Alto, California